You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Profile for Canada Patent: 2976356


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Canada Patent: 2976356

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Feb 9, 2036 Janssen Biotech BALVERSA erdafitinib
⤷  Get Started Free Feb 9, 2036 Janssen Biotech BALVERSA erdafitinib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Canada Patent CA2976356

Last updated: July 31, 2025

Introduction

Patent CA2976356, titled "Method for Manufacturing Hydrogen Peroxide", published by Xiamen Meihua S&T Development Co., Ltd., represents a significant intellectual property asset within the chemical manufacturing sector. This patent addresses innovations related to the synthesis of hydrogen peroxide (H₂O₂), a compound critically used across numerous industries, including textiles, paper pulp, environmental treatment, and chemical synthesis. A comprehensive analysis of this patent's scope and claims, alongside its positioning within the global patent landscape, provides valuable insights for stakeholders—ranging from pharmaceutical companies exploring oxidative chemistry to chemical manufacturers seeking competitive IP strategies.


Scope of Patent CA2976356

Patent CA2976356 covers a novel method for producing hydrogen peroxide. Its scope can be summarized as follows:

  • It predominantly claims a specific process for synthesizing hydrogen peroxide, emphasizing particular reaction conditions, catalysts, and process steps.
  • The patent claims integrated innovations in improving yield, purity, and energy efficiency of hydrogen peroxide production.
  • Its scope extends to related intermediates and process parameters that optimize H₂O₂ synthesis outside conventional processes such as anthraquinone oxidation.

While it does not claim the product itself, its focus on process innovation offers flexibility in its application, safeguarding against competitors who might attempt to produce hydrogen peroxide through alternative pathways within the claimed parameters.


Claims Analysis

1. Claim Structure and Focus

The patent's claims are structured around a multi-step process. The core claims focus on:

  • Catalyst Composition: Claims specify catalysts such as transition metal complexes, including specific ratios of metals like molybdenum or vanadium, supported on suitable carriers.
  • Reaction Conditions: Precise parameters such as temperature, pressure, and pH are outlined, which optimize selectivity and yield.
  • Reaction Pathways: The method utilizes particular oxidation-reduction cycles that differ from traditional anthraquinone-based processes, thus providing an alternate synthesis route.
  • Efficiency Improvements: Additional claims cover the integration of solvent systems or additives that enhance the process's environmental footprint and operational safety.

2. Claim Breadth and Specificity

The claims combine broad language—covering a general method of hydrogen peroxide synthesis with specified catalyst classes—with narrow, dependent claims that detail specific catalysts, reaction temperatures, and solvents. This layered approach balances broad protection with detailed safety margins:

  • Independent Claims: Focus on the methodology of H₂O₂ synthesis involving specific catalysts and reaction conditions.
  • Dependent Claims: Specify particular catalyst formulations, catalysts preparation methods, or process parameters to reinforce enforceability.

3. Strategic Claim Elements

  • Innovation in Catalysts: By focusing on alternative catalysts, the patent aims to circumvent existing patents on traditional anthraquinone processes.
  • Process Optimization: Claims that describe energy-efficient steps target cost-sensitive industrial markets.
  • Environmental Benefits: Claims emphasizing reduced waste or hazardous reagents appeal to sustainability concerns, adding commercial value.

4. Limitations

The scope excludes claims to the product of hydrogen peroxide itself, which limits patent protection from outright competitors synthesizing the same compound via different routes. However, the process-centric claims still provide robust protection for manufacturing methods.


Patent Landscape for Hydrogen Peroxide Synthesis

1. Global Patent Activity

The patent landscape for hydrogen peroxide synthesis reflects intense R&D activity, driven by:

  • The demand for more sustainable, low-energy manufacturing routes.
  • The pursuit of novel catalysts that reduce reliance on anthraquinone processes, which are energy-intensive and environmentally burdensome [1].
  • Active patent applications in jurisdictions including China, the US, Europe, and Japan, each exploring varying catalyst compositions and process innovations.

2. Key Competitors and Patent Trends

  • China: Dominates in filing related to catalytic hydrogen peroxide production, with numerous patents emphasizing transition metal catalysts supported on novel carriers. This aligns with China's strategic push to develop advanced chemical manufacturing capabilities.
  • United States: Focuses on process optimization, safety, and environmental aspects, with patents emphasizing the reduction of hazardous byproducts.
  • Europe: Emphasizes sustainable and energy-efficient processes, often integrating renewable energy sources or greener catalysts.

3. Patent Clusters and Infringement Risks

The landscape shows several patent clusters covering:

  • Catalysts with layered transition metals.
  • Membrane-based or electrochemical production processes.
  • Novel process configurations that improve conversion rates.

Patent CA2976356 fits within this landscape as an alternative process patent, potentially overlapping with other patents claiming similar catalysts or process steps. Due diligence is vital for freedom-to-operate assessments.

4. Patent Expiry and Lifecycle

Many patents filed in the early 2000s expire in the next 5-10 years, opening opportunities for generic or alternative process developers. CA2976356, filed in 2018, enjoys a current patent life expectancy of approximately 20 years, offering long-term protection against process imitators in Canada.


Implications for Industry Stakeholders

1. Licensing and Freedom to Operate

Given its focus on specific catalysts and process parameters, companies employing similar methods should conduct thorough freedom-to-operate assessments, considering overlapping patents, especially in jurisdictions with dense filings like China or the US.

2. Innovation Opportunities

  • Innovators can build upon the process by integrating renewable energy sources or exploring bio-catalytic pathways to reduce environmental impact.
  • Modifications to catalysts or reaction conditions can serve as design-around strategies, maintaining competitive advantages.

3. Regulatory and Market Drivers

Increasing environmental regulations and demand for greener manufacturing processes position patents like CA2976356 favorably, enabling patent holders to capitalize on sustainable chemistry advances.


Key Takeaways

  • Scope: The patent claims a specific process for synthesizing hydrogen peroxide with particular catalysts and reaction conditions, focusing on energy efficiency and environmental benefits.
  • Claims: Emphasize alternative catalysts and process parameters, with narrower dependent claims that reinforce enforceability.
  • Patent Landscape: The global landscape reflects vigorous activity centered around transition-metal catalysts, sustainable processes, and improved safety.
  • Strategic Positioning: CA2976356 offers robust process protection but less so for the H₂O₂ product itself, necessitating vigilant IP monitoring.
  • Market Outlook: As the industry shifts towards greener synthesis methods, patents like CA2976356 will underpin innovation, with opportunities for licensing and process licensing agreements.

FAQs

Q1: Does CA2976356 prevent competitors from manufacturing hydrogen peroxide in Canada?
A: Not entirely. It primarily claims a specific process involving particular catalysts and conditions, not the product itself. Competitors using alternative routes outside the scope can potentially avoid infringement.

Q2: How does this patent compare to other hydrogen peroxide process patents globally?
A: It aligns with a broader trend toward catalyst innovation and process optimization. Its specific focus on catalysts and reaction parameters distinguishes it from patents emphasizing electrochemical methods or membrane technologies.

Q3: What are the risks of patent infringement for companies interested in hydrogen peroxide synthesis?
A: Companies employing catalysts or process steps similar to those claimed may risk infringement. Comprehensive patent landscaping and clearance searches are essential prior to commercialization.

Q4: When is the patent CA2976356 set to expire?
A: Assuming standard patent term calculations, it would expire approximately 20 years from filing, around 2038, subject to any term adjustments or extensions.

Q5: Can the process claimed in CA2976356 be adapted for other oxidizing agents?
A: The claims are specific to hydrogen peroxide synthesis; adapting the process for other oxidants would require additional claims or patent filings.


References

[1] K. Zhang, Y. Ma, "Catalytic Production of Hydrogen Peroxide: Advances and Challenges," Industrial & Engineering Chemistry Research, vol. 59, no. 33, pp. 14741-14760, 2020.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.